GlassScriptPhysician profile
Timothy Robert Hauser
NPI 1437386133
$3,882.61
in general payments reported to CMS, 2019-2025
25 companies · $1,225 in 2025
The $1,225 reported for 2025 was more than what 80% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,169 · 2020: $97.79 · 2021: $118 · 2022: $197 · 2023: $694 · 2024: $383 · 2025: $1,225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,189 · Education: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,188.92 |
| Education | $112.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Veran Medical Technologies, INC. | $1,139.24 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $620.16 | 2020-2025 | Tezspire, Fasenra, Airsupra |
| Regeneron Healthcare Solutions, INC. | $400.09 | 2019-2025 | Dupixent |
| Glaxosmithkline, LLC. | $375.09 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $273.83 | 2023-2025 | |
| Pulmonx Corporation | $141.66 | 2024-2025 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.69 | 2019-2025 | Ofev, Stiolto Respimat |
| Baxter Healthcare | $117.74 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| United Therapeutics Corporation | $85.28 | 2023-2024 | Tyvaso, Orenitram, Remodulin |
| Jazz Pharmaceuticals INC. | $80.17 | 2025 | |
| Insmed, INC. | $78.59 | 2025 | Arikayce |
| Grifols USA, LLC | $54.46 | 2021-2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $49.06 | 2023-2024 | Glassia |
| Axsome Therapeutics, INC. | $45.11 | 2024-2025 | Sunosi |
| Actelion Pharmaceuticals US, INC. | $42.44 | 2023-2024 | Opsumit, Uptravi |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $35.56 | 2023 | Inspire |
| Inogen, INC. | $35.55 | 2025 | |
| Pfizer INC. | $33.48 | 2022-2024 | |
| Amgen INC. | $32.42 | 2025 | Tezspire |
| Mylan Specialty L.P. | $30.67 | 2020-2021 | |
| Abiomed | $27.37 | 2025 | |
| Verona Pharma, INC. | $20.78 | 2025 | Ohtuvayre |
| Philips North America LLC | $16.48 | 2025 | Vest Therapy Und |
| Advanced Respiratory, INC | $15.88 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.81 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Hauser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.